Corrigendum to "Transcriptomic data of Bevacizumab-adapted colorectal adenocarcinoma cells HCT-116" [Data In Brief, Volume 48, (Available online 17 March 2023) 1-9/Article 109069]

Cesare Sala¹, Tiziano Lottini¹, Elena Lastraioli^{1

2}, Federico Alessandro Ruffinatti³, Luca Visentin³, Annarosa Arcangeli^{1

2}

Affiliations

¹ Department of Experimental and Clinical Medicine, University of Florence, Viale GB Morgagni 50, 50134 Florence, Italy.
² Complex Dynamics Study Centre (CSDC), University of Florence, 50100 Florence, Italy.
³ Department of Life Sciences and Systems Biology, University of Torino, Via Accademia Albertina 13, 10123 Torino, Italy.

Published Erratum

Cesare Sala et al. Data Brief. 2023.

. 2023 Jun 24:49:109343.

doi: 10.1016/j.dib.2023.109343. eCollection 2023 Aug.

Cesare Sala¹, Tiziano Lottini¹, Elena Lastraioli^{1

2}, Federico Alessandro Ruffinatti³, Luca Visentin³, Annarosa Arcangeli^{1

2}

¹ Department of Experimental and Clinical Medicine, University of Florence, Viale GB Morgagni 50, 50134 Florence, Italy.
² Complex Dynamics Study Centre (CSDC), University of Florence, 50100 Florence, Italy.
³ Department of Life Sciences and Systems Biology, University of Torino, Via Accademia Albertina 13, 10123 Torino, Italy.

Abstract

[This corrects the article DOI: 10.1016/j.dib.2023.109069.].

Transcriptomic data of bevacizumab-adapted colorectal adenocarcinoma cells HCT-116.
Cesare S, Tiziano L, Elena L, Alessandro RF, Luca V, Annarosa A. Cesare S, et al. Data Brief. 2023 Mar 17;48:109069. doi: 10.1016/j.dib.2023.109069. eCollection 2023 Jun. Data Brief. 2023. PMID: 37066085 Free PMC article.